1
|
Roehrborn CG: Male lower urinary tract
symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin
North Am. 95:87–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ho CK and Habib FK: Estrogen and androgen
signaling in the pathogenesis of BPH. Nat Rev Urol. 8:29–41. 2011.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Huggins C and Hodges CV: Studies on
prostatic cancer. I. The effect of castration, of estrogen and of
androgen injection on serum phosphatases in metastatic carcinoma of
the prostate. 1941. J Urol. 168:9–12. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Izumi K, Li L and Chang C: Androgen
receptor and immune inflammation in benign prostatic hyperplasia
and prostate cancer. Clin Investig (Lond). 4:935–950. 2014.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Kramer G, Mitteregger D and Marberger M:
Is benign prostatic hyperplasia (BPH) an immune inflammatory
disease? Eur Urol. 51:1202–1216. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Shoskes DA: Phytotherapy in chronic
prostatitis. Urology. 60:(Suppl 6). S35–S37; discussion 37. 2002.
View Article : Google Scholar
|
7
|
Hirsch IH: Integrative urology: A spectrum
of complementary and alternative therapy. Urology. 56:185–189.
2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Guo QL, Ding QL and Wu ZQ: Effect of
baicalein on experimental prostatic hyperplasia in rats and mice.
Biol Pharm Bull. 27:333–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Rick FG, Schally AV, Block NL, Nadji M,
Szepeshazi K, Zarandi M, Vidaurre I, Perez R, Halmos G and
Szalontay L: Antagonists of growth hormone-releasing hormone (GHRH)
reduce prostate size in experimental benign prostatic hyperplasia.
Proc Natl Acad Sci USA. 108:3755–3760. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Maggi CA, Manzini S, Giuliani S and Meli
A: Infravesical outflow obstruction in rats: A comparison of two
models. Gen Pharmacol. 20:345–349. 1989. View Article : Google Scholar : PubMed/NCBI
|
11
|
Marinese D, Patel R and Walden PD:
Mechanistic investigation of the adrenergic induction of ventral
prostate hyperplasia in mice. Prostate. 54:230–237. 2003.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Miller J and Tarter TH: Combination
therapy with dutasteride and tamsulosin for the treatment of
symptomatic enlarged prostate. Clin Interv Aging. 4:251–258.
2009.PubMed/NCBI
|
13
|
Wei JT, Calhoun E and Jacobsen SJ:
Urologic diseases in America project: Benign prostatic hyperplasia.
J Urol. 173:1256–1261. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Izumi K, Mizokami A, Lin WJ, Lai KP and
Chang C: Androgen receptor roles in the development of benign
prostate hyperplasia. Am J Pathol. 182:1942–1949. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Pawlicki B, Zielinski H and Dabrowski M:
Role of apoptosis and chronic prostatitis in the pathogenesis of
benign prostatic hyperplasia. Pol Merkur Lekarski. 17:307–310.
2004.(In Polish). PubMed/NCBI
|
16
|
Corona G, Vignozzi L, Rastrelli G, Lotti
F, Cipriani S and Maggi M: Benign prostatic hyperplasia: A new
metabolic disease of the aging male and its correlation with sexual
dysfunctions. Int J Endocrinol. 2014:329–456. 2014. View Article : Google Scholar
|
17
|
Carson C III and Rittmaster R: The role of
dihydrotestosterone in benign prostatic hyperplasia. Urology.
61(4): Suppl 1. S2–S7. 2003. View Article : Google Scholar
|
18
|
Steers WD: 5alpha-reductase activity in
the prostate. Urology. 58(6): Suppl 1. S17–S24; discussion 24.
2001. View Article : Google Scholar
|
19
|
Meyer-Siegler KL and Vera PL: Substance P
induced release of macrophage migration inhibitory factor from rat
bladder epithelium. J Urol. 171:1698–1703. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang X, Zhang Q, Zhang Z, Na Y and Guo Y:
Apoptosis profiles in benign prostatic hyperplasia: Close
associations of cell kinetics with percent area density of
histologic composition. Urology. 68:905–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Nuñez G, Benedict MA, Hu Y and Inohara N:
Caspases: The proteases of the apoptotic pathway. Oncogene.
17:3237–3245. 1998. View Article : Google Scholar : PubMed/NCBI
|